A detailed history of Bay Colony Advisory Group, Inc D transactions in Abb Vie Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 10,496 shares of ABBV stock, worth $1.89 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
10,496
Previous 10,501 0.05%
Holding current value
$1.89 Million
Previous $1.8 Million 15.05%
% of portfolio
0.33%
Previous 0.31%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $819 - $996
-5 Reduced 0.05%
10,496 $2.07 Million
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $2,476 - $2,892
-16 Reduced 0.15%
10,501 $1.8 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $73,836 - $84,130
-462 Reduced 4.21%
10,517 $1.92 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $225,939 - $254,460
1,642 Added 17.59%
10,979 $1.7 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $494,950 - $572,978
-3,705 Reduced 28.41%
9,337 $1.39 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $71,687 - $89,210
541 Added 4.33%
13,042 $1.76 Million
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $88,501 - $101,922
-612 Reduced 4.67%
12,501 $1.99 Million
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $88,795 - $106,488
-642 Reduced 4.67%
13,113 $2.12 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $73,547 - $84,353
-548 Reduced 3.83%
13,755 $1.85 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $178,768 - $227,273
1,299 Added 9.99%
14,303 $2.05 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $525,940 - $652,543
-3,985 Reduced 23.46%
13,004 $2.11 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $48,665 - $61,576
-453 Reduced 2.6%
16,989 $2.3 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $12,448 - $14,131
117 Added 0.68%
17,442 $1.88 Million
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $22,304 - $24,848
212 Added 1.24%
17,325 $1.95 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $262,808 - $289,320
2,569 Added 17.66%
17,113 $1.85 Million
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $78,477 - $105,953
-975 Reduced 6.28%
14,544 $1.56 Million
Q3 2020

Nov 25, 2020

BUY
$85.91 - $100.83 $40,377 - $47,390
470 Added 3.12%
15,519 $1.36 Million
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $222,311 - $297,485
-3,030 Reduced 16.76%
15,049 $1.48 Million
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $245,035 - $371,504
3,799 Added 26.6%
18,079 $1.38 Million
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $1.03 Million - $1.29 Million
14,280 New
14,280 $1.25 Million
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $1.49 Million - $1.86 Million
-20,605 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $1.06 Million - $1.27 Million
16,784 Added 439.26%
20,605 $1.56 Million
Q2 2019

Jul 17, 2019

BUY
$65.7 - $83.98 $251,039 - $320,887
3,821 New
3,821 $278,000
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $88,020 - $97,851
-990 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $88,882 - $105,167
990 New
990 $92,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.